Invitation to Roche Pharma Day 2026 Donnerstag, 13. August 2026 - 10:55

Investor Update

Invitation to Roche Pharma Day 2026

The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 28 September 2026, starting at 09:00 BST and will finish at 14:30 BST with a reception. The Roche Pharma Day will address the following topics: Pharma strategy and commercial growth drivers R&D Excellence AI in early drug development Pipeline updates Oncology / Hematology, Neurology, Ophthalmology, Immunology, CVRM Presenters will include: Teresa Graham, CEO Roche Pharmaceuticals Levi Garraway,CMO and Global Head of Product Development Aviv Regev, Global Head of gRED Alan Hippe, CFO Roche Group Matt Hellmann,SVP and Global Head of Oncology Product Development Hideki Garren,SVP and Global Head of Neurology Product Development Larry Tsai,SVP and Global Head of Immunology Product Development Christopher Brittain, SVP and Global Head of Ophthalmology Product Development Manu Chakravarthy,SVP and Global Head of CVRM Product Development You will have the opportunity to meet senior management during the event. Meeting information: Date/Time (BST): Monday, 28 September 2026 09:00 Registration 09:30 Event starts 14:30 Event ends, followed by refreshments with the Roche Management Team Venue Pan Pacific London 80 Houndsditch London EC3A 7AB >map To register for the event, please follow this link(passcode: Pharma2026) The slideswill be available for download at 08:00 BST on the day of the event. >click here Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration required). Please pre-register for the webinar here. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail toinvestor.relations@roche.com . A replay of the event will be available via > ir.roche.com privacy notice Best regards,
Bruno Eschli Head of Investor Relations

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com

Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com